Mycobacteria attenuate nociceptive responses by formyl peptide receptor triggered opioid peptide release from neutrophils

PLoS Pathogens

Volumn 5, Issue 4, 2009, Pages

  Rittner, Heike L ^a,b   Hackel, Dagmar ^a,b   Voigt, Philipp ^a   Mousa, Shaaban ^a   Stolz, Andrea ^a   Labuz, Dominika ^a   Schäfer, Michael ^a   Schaefer, Michael ^a   Stein, Christoph ^a   Brack, Alexander ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BETA ENDORPHIN; CALCIUM; CYCLOSPORINE H; FORMYLPEPTIDE RECEPTOR; FREUND ADJUVANT; METENKEPHALIN; OPIATE PEPTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN INHIBITOR; TERT BUTYLOXYCARBONYLPHENYLALANYLLEUCYLPHENYLALANYLLEUCYLPHENYLALANINE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 2 AGONIST; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 4 AGONIST; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CYCLOSPORIN; CYCLOSPORIN H; OPIATE RECEPTOR; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CHELATION; CONTROLLED STUDY; EMBRYO; ENZYME INHIBITION; HEAT; HUMAN; HUMAN CELL; INFLAMMATORY PAIN; LEUKOCYTE ACTIVATION; MALE; MECHANICAL NOCICEPTIVE THRESHOLD; MYCOBACTERIUM BUTYRICUM; NEUTROPHIL; NOCICEPTION; NONHUMAN; PAIN; PAIN THRESHOLD; RADIOIMMUNOASSAY; RAT; THERMAL NOCICEPTIVE THRESHOLD; WITHDRAWAL REFLEX; ANALYSIS OF VARIANCE; ANIMAL; DRUG ANTAGONISM; DRUG POTENTIATION; IMMUNOLOGY; METABOLISM; MONOCYTE; MYCOBACTERIUM; NOCICEPTIVE RECEPTOR; WISTAR RAT;

CORYNEBACTERINEAE; MYCOBACTERIUM BUTYRICUM; RATTUS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANALYSIS OF VARIANCE; ANIMALS; CALCIUM; CYCLOSPORINE; ENKEPHALIN, METHIONINE; FREUND'S ADJUVANT; HUMANS; MALE; MONOCYTES; MYCOBACTERIUM; NEUROTRANSMITTER AGENTS; NEUTROPHILS; NOCICEPTORS; OPIOID PEPTIDES; PAIN; RATS; RATS, WISTAR; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, OPIOID; TOLL-LIKE RECEPTORS;

EID: 66349103375     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000362     Document Type: Article

References (81)

1. Amaral FA, Sachs D, Costa VV, Fagundes CT, Cisalpino D, et al. (2008) Commensal microbiota is fundamental for the development of inflammatory pain. Proc Natl Acad Sci U S A 105: 2193-2197.
2. Djouhri L, Koutsikou S, Fang X, McMullan S, Lawson SN (2006) Spontaneous pain, both neuropathic and inflammatory, is related to frequency of spontaneous firing in intact C-fiber nociceptors. J Neurosci 26: 1281-1292.
3. Xiao WH, Bennett GJ (2008) C-fiber spontaneous discharge evoked by chronic inflammation is suppressed by a long-term infusion of lidocaine yielding nanogram per milliliter plasma levels. Pain 137: 218-228.
4. Rittner HL, Machelska H, Stein C (2005) Leukocytes in the regulation of pain and analgesia. J Leukoc Biol 79: 1215-1222.
5. Tedesco LS, Fuseler J, Grisham M, Wolf R, Roerig SC (2002) Therapeutic administration of nitric oxide synthase inhibitors reverses hyperalgesia but not inflammation in a rat model of polyarthritis. Pain 95: 215-223.
6. Martinez V, Melgar S (2008) Lack of colonic inflammation-induced acute visceral hypersensitivity to colorectal distension in Na(v)1.9 knockout mice. Eur J Pain 12: 934-944.
7. Cunha TM, Barsante MM, Guerrero AT, Verri WA Jr, Ferreira SH, et al. (2008) Treatment with DF 2162, a non-competitive allosteric inhibitor of CXCR1/2, diminishes neutrophil influx and inflammatory hypernociception in mice. Br J Pharmacol 154: 460-470.
8. Bjorling DE, Wang ZY, Boldon K, Bushman W (2008) Bacterial cystitis is accompanied by increased peripheral thermal sensitivity in mice. J Urol 179: 759-763.
9. Tanga FY, Nutile-McMenemy N, DeLeo JA (2005) The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci U S A 102: 5856-5861.
10. Kim D, Kim MA, Cho IH, Kim MS, Lee S, et al. (2007) A critical role of tolllike receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J Biol Chem 282: 14975-14983.
11. Pieretti S, Di Giannuario A, De Felice M, Perretti M, Cirino G (2004) Stimulusdependent specificity for annexin 1 inhibition of the inflammatory nociceptive response: the involvement of the receptor for formylated peptides. Pain 109: 52-63.
12. Stein C, Schäfer M, Machelska H (2003) Attacking pain at its source: new perspectives on opioids. Nat Med 9: 1003-1008.
13. Brack A, Rittner HL, Machelska H, Shaqura M, Mousa SA, et al. (2004) Endogenous peripheral antinociception in early inflammation is not limited by the number of opioid-containing leukocytes but by opioid receptor expression. Pain 108: 67-75.
14. Brack A, Rittner HL, Machelska H, Leder K, Mousa SA, et al. (2004) Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells. Pain 112: 229-238.
15. Brack A, Labuz D, Schlitz A, Rittner HL, Machelska H, et al. (2004) Tissue monocytes/macrophages in inflammation: hyperalgesia versus opioid-mediated peripheral antinociception. Anesthesiology 101: 204-211.
16. Schäfer M, Mousa SA, Zhang Q, Carter L, Stein C (1996) Expression of corticotrophin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. Proc Natl Acad Sci U S A 93: 6096-6100.
17. Rittner HL, Labuz D, Schaefer M, Mousa SA, Schulz S, et al. (2006) Pain control by CXCR2 ligands through Ca2+-regulated release of opioid peptides from polymorphonuclear cells. FASEB J 20: 2627-2629.
18. Rittner HL, Labuz D, Richter JF, Brack A, Schäfer M, et al. (2007) CXCR1/2 ligands induce p38 MAPK-dependent translocation and release of opioid peptides from primary granules in vitro and in vivo. Brain Behav Immun 21: 1021-1032.
19. Stein C, Hassan AH, Lehrberger K, Giefing J, Yassouridis A (1993) Local analgesic effect of endogenous opioid peptides. Lancet 342: 321-324.
20. Sitte N, Busch M, Mousa SA, Labuz D, Rittner H, et al. (2007) Lymphocytes upregulate signal sequence-encoding proopiomelanocortin mRNA and betaendorphin during painful inflammation in vivo. J Neuroimmunol 183: 133-145.
21. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, et al. (1999) Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 163: 3920-3927.
22. Jo EK, Yang CS, Choi CH, Harding CV (2007) Intracellular signaling cascades regulating innate immune responses to Mycobacteria: branching out from Tolllike receptors. Cell Microbiol 9: 1087-1098.
23. Gripentrog JM, Mills JS, Saari GJ, Miettinen HM (2008) Variable responses of formyl peptide receptor haplotypes toward bacterial peptides. Immunogenetics 60: 83-93.
24. Dalpiaz A, Spisani S, Biondi C, Fabbri E, Nalli M, et al. (2003) Studies on human neutrophil biological functions by means of formyl-peptide receptor agonists and antagonists. Curr Drug Targets Immune Endocr Metabol Disord 3: 33-42.
25. Durr MC, Kristian SA, Otto M, Matteoli G, Margolis PS, et al. (2006) Neutrophil chemotaxis by pathogen-associated molecular patterns-formylated peptides are crucial but not the sole neutrophil attractants produced by Staphylococcus aureus. Cell Microbiol 8: 207-217.
26. Parker LC, Whyte MK, Dower SK, Sabroe I (2005) The expression and roles of Toll-like receptors in the biology of the human neutrophil. J Leukoc Biol 77: 886-892.
27. Bhatt K, Salgame P (2007) Host innate immune response to Mycobacterium tuberculosis. J Clin Immunol 27: 347-362.
28. Godaly G, Young DB (2005) Mycobacterium bovis bacille Calmette Guerin infection of human neutrophils induces CXCL8 secretion by MyD88-dependent TLR2 and TLR4 activation. Cell Microbiol 7: 591-601.
29. Hayashi F, Means TK, Luster AD (2003) Toll-like receptors stimulate human neutrophil function. Blood 102: 2660-2669.
30. Sabroe I, Prince LR, Jones EC, Horsburgh MJ, Foster SJ, et al. (2003) Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span. J Immunol 170: 5268-5275.
31. Stenfeldt AL, Karlsson J, Wenneras C, Bylund J, Fu H, et al. (2007) Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor. Inflammation 30: 224-229.
32. Selvatici R, Falzarano S, Mollica A, Spisani S (2006) Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils. Eur J Pharmacol 534: 1-11.
33. Locati M, Riboldi E, Bonecchi R, Transidico P, Bernasconi S, et al. (2001) Selective induction of phospholipase D1 in pathogen-activated human monocytes. Biochem J 358: 119-125.
34. Sodhi A, Biswas SK (2002) fMLP-induced in vitro nitric oxide production and its regulation in murine peritoneal macrophages. J Leukoc Biol 71: 262-270.
35. Galdiero M, Galdiero M, Finamore E, Rossano F, Gambuzza M, et al. (2004) Haemophilus influenzae porin induces Toll-like receptor 2-mediated cytokine production in human monocytes and mouse macrophages. Infect Immun 72: 1204-1209.
36. Sabroe I, Dower SK, Whyte MK (2005) The role of Toll-like receptors in the regulation of neutrophil migration, activation, and apoptosis. Clin Infect Dis 41 Suppl 7: S421-426.
37. Chun T, Serbina NV, Nolt D, Wang B, Chiu NM, et al. (2001) Induction of M3- restricted cytotoxic T lymphocyte responses by N-formylated peptides derived from Mycobacterium tuberculosis. J Exp Med 193: 1213-1220.
38. Le Y, Murphy PM, Wang JM (2002) Formyl-peptide receptors revisited. Trends Immunol 23: 541-548.
39. Wenzel-Seifert K, Seifert R (1993) Cyclosporin H is a potent and selective formyl peptide receptor antagonist. Comparison with N-t-butoxycarbonyl-Lphenylalanyl- L-leucyl-L-phenylalanyl-L- leucyl-L-phenylalanine and cyclosporins A, B, C, D, and E. J Immunol 150: 4591-4599.
40. Loor F, Tiberghien F, Wenandy T, Didier A, Traber R (2002) Cyclosporins: structure-activity relationships for the inhibition of the human FPR1 formylpeptide receptor. J Med Chem 45: 4613-4628.
41. Abdel-Latif D, Steward M, Macdonald DL, Francis GA, Dinauer MC, et al. (2004) Rac2 is critical for neutrophil primary granule exocytosis. Blood 104: 832-839.
42. Rittner HL, Mousa SA, Labuz D, Beschmann K, Schäfer M, et al. (2006) Selective local PMN recruitment by CXCL1 or CXCL2/3 injection does not cause inflammatory pain. J Leukoc Biol 79: 1022-1032.
43. Stein C, Hassan AH, Przewlocki R, Gramsch C, Peter K, et al. (1990) Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci U S A 87: 5935-5939.
44. Schäfer M, Carter L, Stein C (1994) Interleukin 1 beta and corticotropinreleasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci U S A 91: 4219-4223.
45. Sabroe I, Jones EC, Usher LR, Whyte MK, Dower SK (2002) Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J Immunol 168: 4701-4710.
46. Ahmad R, El Bassam S, Cordeiro P, Menezes J (2008) Requirement of TLR2- mediated signaling for the induction of IL-15 gene expression in human monocytic cells by HSV-1. Blood 112: 2360-2368.
47. Wang R, Stephens J, Lacy MJ (2003) Characterization of monoclonal antibody HTA125 with specificity for human TLR4. Hybrid Hybridomics 22: 357-365.
48. Yang S, Tamai R, Akashi S, Takeuchi O, Akira S, et al. (2001) Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture. Infect Immun 69: 2045-2053.
49. Hattar K, Grandel U, Moeller A, Fink L, Iglhaut J, et al. (2006) Lipoteichoic acid (LTA) from Staphylococcus aureus stimulates human neutrophil cytokine release by a CD14-dependent, Toll-like-receptor-independent mechanism: Autocrine role of tumor necrosis factor-[alpha] in mediating LTA-induced interleukin-8 generation. Crit Care Med 34: 835-841.
50. Moller AS, Ovstebo R, Westvik AB, Joo GB, Haug KB, et al. (2003) Effects of bacterial cell wall components (PAMPs) on the expression of monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and the chemokine receptor CCR2 by purified human blood monocytes. J Endotoxin Res 9: 349-360.
51. Lotz S, Aga E, Wilde I, van Zandbergen G, Hartung T, et al. (2004) Highly purified lipoteichoic acid activates neutrophil granulocytes and delays their spontaneous apoptosis via CD14 and TLR2. J Leukoc Biol 75: 467-477.
52. Pivarcsi A, Bodai L, Rethi B, Kenderessy-Szabo A, Koreck A, et al. (2003) Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol 15: 721-730.
53. Strassheim D, Asehnoune K, Park JS, Kim JY, He Q, et al. (2004) Phosphoinositide 3-kinase and Akt occupy central roles in inflammatory responses of Toll-like receptor 2-stimulated neutrophils. J Immunol 172: 5727-5733.
54. Bellocchio S, Moretti S, Perruccio K, Fallarino F, Bozza S, et al. (2004) TLRs govern neutrophil activity in aspergillosis. J Immunol 173: 7406-7415.
55. Radsak MP, Salih HR, Rammensee HG, Schild H (2004) Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival. J Immunol 172: 4956-4963.
56. He R, Tan L, Browning DD, Wang JM, Ye RD (2000) The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor. J Immunol 165: 4598-4605.
57. Marasco WA, Fantone JC, Freer RJ,Ward PA (1983) Characterization of the rat neutrophil formyl peptide chemotaxis receptor. Am J Pathol 111: 273-281.
58. Fillion I, Ouellet N, Simard M, Bergeron Y, Sato S, et al. (2001) Role of chemokines and formyl peptides in pneumococcal pneumonia-induced monocyte/ macrophage recruitment. J Immunol 166: 7353-7361.
59. Gauthier JF, Fortin A, Bergeron Y, Dumas MC, Champagne ME, et al. (2007) Differential contribution of bacterial N-formyl-methionyl-leucyl- phenylalanine and host-derived CXC chemokines to neutrophil infiltration into pulmonary alveoli during murine pneumococcal pneumonia. Infect Immun 75: 5361-5367.
60. La M, M DA, Bandiera S, Di Filippo C, Oliani SM, et al. (2001) Annexin 1 peptides protect against experimental myocardial ischemia-reperfusion: analysis of their mechanism of action. Faseb J 15: 2247-2256.
61. Itou T, Collins LV, Thoren FB, Dahlgren C, Karlsson A (2006) Changes in activation states of murine polymorphonuclear leukocytes (PMN) during inflammation: a comparison of bone marrow and peritoneal exudate PMN. Clin Vaccine Immunol 13: 575-583.
62. Remick DG, Green LB, Newcomb DE, Garg SJ, Bolgos GL, et al. (2001) CXC chemokine redundancy ensures local neutrophil recruitment during acute inflammation. Am J Pathol 159: 1149-1157.
63. Mousa SA, Straub RH, Schafer M, Stein C (2007) Beta-endorphin, Metenkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis. Ann Rheum Dis 66: 871-879.
64. Heurich M, Mousa SA, Lenzner M, Morciniec P, Kopf A, et al. (2007) Influence of pain treatment by epidural fentanyl and bupivacaine on homing of opioidcontaining leukocytes to surgical wounds. Brain Behav Immun 21: 544-552.
65. Likar R, Mousa SA, Steinkellner H, Koppert W, Philippitsch G, et al. (2007) Involvement of intra-articular corticotropin-releasing hormone in postoperative pain modulation. Clin J Pain 23: 136-142.
66. Carp H (1982) Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J Exp Med 155: 264-275.
67. Shawar SM, Rich RR, Becker EL (1995) Peptides from the amino-terminus of mouse mitochondrially encoded NADH dehydrogenase subunit 1 are potent chemoattractants. Biochem Biophys Res Commun 211: 812-818.
68. Rabiet MJ, Huet E, Boulay F (2005) Human mitochondria-derived Nformylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR. Eur J Immunol 35: 2486-2495.
69. Buvanendran A, Kroin JS, Berger RA, Hallab NJ, Saha C, et al. (2006) Upregulation of prostaglandin E2 and interleukins in the central nervous system and peripheral tissue during and after surgery in humans. Anesthesiology 104: 403-410.
70. Stein C, Millan MJ, Herz A (1988) Unilateral inflammation of the hindpaw in rats as a model of prolonged noxious stimulation: alterations in behavior and nociceptive thresholds. Pharmacol Biochem Behav 31: 455-451.
71. Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110.
72. Cerchiaro GA, Scavone C, Texeira S, Sannomiya P (2001) Inducible nitric oxide synthase in rat neutrophils: role of insulin. Biochem Pharmacol 62: 357-362.
73. Cabot PJ, Carter L, Gaiddon C, Zhang Q, Schäfer M, et al. (1997) Immune cellderived beta-endorphin. Production, release, and control of inflammatory pain in rats. J Clin Invest 100: 142-148.
74. Vindrola O, Padros MR, Sterin-Prync A, Ase A, Finkielman S, et al. (1990) Proenkephalin system in human polymorphonuclear cells. Production and release of a novel 1.0-kD peptide derived from synenkephalin. J Clin Invest 86: 531-537.
75. Simons MP, Moore JM, Kemp TJ, Griffith TS (2007) Identification of the mycobacterial subcomponents involved in the release of tumor necrosis factorrelated apoptosis-inducing ligand from human neutrophils. Infect Immun 75: 1265-1271.
76. Rittner HL, Brack A, Machelska H, Mousa SA, Bauer M, et al. (2001) Opioid peptide expressing leukocytes - Identification, recruitment and simultaneously increasing inhibiton of inflammatory pain. Anesthesiology 95: 500-508.
77. Brack A, Rittner HL, Machelska H, Beschmann K, Sitte N, et al. (2004) Mobilization of opioid-containing polymorphonuclear cells by hematopoietic growth factors and influence on inflammatory pain. Anesthesiology 100: 149-157.
78. Brock C, Schaefer M, Reusch HP, Czupalla C, Michalke M, et al. (2003) Roles of G beta gamma in membrane recruitment and activation of p110 gamma/ p101 phosphoinositide 3-kinase gamma. J Cell Biol 160: 89-99.
79. Lenz JC, Reusch HP, Albrecht N, Schultz G, Schaefer M (2002) Ca2+- controlled competitive diacylglycerol binding of protein kinase C isoenzymes in living cells. J Cell Biol 159: 291-302.
80. Mousa SA, Machelska H, Schäfer M, Stein C (2002) Immunohistochemical localization of endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain. J Neuroimmunol 126: 5-15.
81. Mousa SA, Bopaiah CP, Stein C, Schäfer M (2003) Involvement of corticotropin-releasing hormone receptor subtypes 1 and 2 in peripheral opioid-mediated inhibition of inflammatory pain. Pain 106: 297-307.